ProKidney • PROK
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Timothy Bertram, PhD$167M
Market Cap • 25/04/20242021
(há 3 anos)
2022
(2 years ago)
NASDAQ
Listagem
Winston-Salem
Sede • North Carolina87
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
PROKSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.